Dashboard
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.27 times
Low Debt Company with Strong Long Term Fundamental Strength
The company has declared Positive results for the last 6 consecutive quarters
Stock is technically in a Bearish range
With ROCE of 17.3, it has a Very Attractive valuation with a 2.5 Enterprise value to Capital Employed
Majority shareholders : Promoters
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
Asarfi Hospital for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Asarfi Hospital Ltd is Rated Hold by MarketsMOJO
Asarfi Hospital Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 03 Nov 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Asarfi Hospital Ltd Upgraded to Hold by MarketsMOJO on Improving Fundamentals and Technicals
Asarfi Hospital Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and sustained robust financial performance. The upgrade, effective from 3 November 2026, is underpinned by positive shifts in technical trends, solid valuation metrics, encouraging financial trends, and a stable quality assessment, signalling a more balanced outlook for investors in this micro-cap hospital sector stock.
Read More
Asarfi Hospital Ltd Forms Death Cross, Signalling Potential Bearish Trend
Asarfi Hospital Ltd has recently experienced a significant technical development as its 50-day moving average (DMA) crossed below the 200-day moving average, forming a Death Cross. This event is widely regarded by market analysts as a bearish signal, indicating a potential deterioration in the stock’s trend and raising concerns about its long-term momentum.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
19-Nov-2026 | Source : BSEWe wish to inform you that Asarfi Hospital Limited has scheduled a Conference Call with Analysts / Investors on Tuesday November 24 2026 at 04:00 P.M. (IST) to discuss the Audited Financial Results of the Company for the quarter and half year ended September 30 2026.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
14-Nov-2026 | Source : BSEOutcome of Press Release/Media Release Under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations2015.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
13-Nov-2026 | Source : BSESubmission of Press Release of the Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended 30 September 2026.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Harendra Singh (18.78%)
Gopal Singh (2.4%)
30.92%
Quarterly Results Snapshot (Consolidated) - Sep'26 - QoQ
QoQ Growth in quarter ended Sep 2026 is 11.59% vs 5.06% in Jun 2026
QoQ Growth in quarter ended Sep 2026 is 42.62% vs 8.93% in Jun 2026
Half Yearly Results Snapshot (Standalone) - Mar'25
Growth in half year ended Mar 2025 is 24.17% vs 22.01% in Sep 2024
Growth in half year ended Mar 2025 is 47.86% vs 107.01% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is -7.00% vs 5.45% in Sep 2026
YoY Growth in nine months ended Dec 2024 is -12.91% vs -28.17% in Sep 2026
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 42.47% vs 44.29% in Mar 2025
YoY Growth in year ended Mar 2026 is 57.47% vs 154.33% in Mar 2025